Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

KRASG12C IN-17

SKU: orb3173929

Description

KRASG12C IN-17 is an orally active covalent inhibitor of KRASG12C, demonstrating potent inhibitory activity in KRASG12C-mutant cancer cells (NCI-H23 IC50 = 0.7 nM; NCI-H358 IC50 = 0.5 nM). It efficiently and irreversibly forms a covalent bond with KRASG12C in both GDP-bound and GMPPNP-bound states, with a modification rate exceeding 96%. KRASG12C IN-17 is applicable for research on KRAS-driven tumors, including colorectal cancer.

Research Area

Signal Transduction

Images & Validation

Key Properties

CAS Number2966924-23-0
MW650.71
FormulaC37H33F3N6O2
SMILESC(OC=1N=C(C2=C(N1)C(F)=C(C(F)=C2)C=3C4=C(C=CC3)C=CC=C4C#C)N5C[C@H](CC#N)N(C(C(=C)F)=O)CC5)C67N(CCC6)CCC7
TargetRas

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • SOS1-IN-17 [orb2814076]

    541.61

    C29H34F3N5O2

    50 mg, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information